Medicine · 20 Nov 2026
Risk of major adverse cardiovascular events and all-cause mortality across chronic kidney disease stages: A population-based retrospective cohort study in South Korea
Yookyung Leeh-index 8, Doo Woong Lee, Ye Seol Lee, Sung Hoon Jeong, Miji Kim, Hyunmi Oh, Soo Jin Kim, Hyang-Lim Lee, Ja-Ho Leighh-index 16
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Chronic kidney disease (CKD) is associated with increased cardiovascular and all-cause mortality risk. However, few studies have assessed whether these risks vary across CKD stages in Asian populations. Using Korean National Health Insurance data (2016–2020), we analyzed a cohort of 51,352 individuals newly diagnosed with CKD. We compared incidence rates of major adverse cardiovascular events (MACE) and all-cause mortality across CKD stages. Model 1 adjusted for age and sex; Model 2, the primary adjusted model, additionally adjusted for income and health insurance coverage type. All covariates were ascertained on or before cohort entry. During follow-up, 9708 participants (18.9%) experienced MACE and 7091 (13.8%) died. Compared with stage 1 CKD, stage 5 CKD with dialysis was associated with higher hazards of MACE (Model 2 hazard ratio = 4.67; 95% confidence interval = 4.24–5.13) and all-cause mortality (hazard ratio = 5.61; 95% confidence interval = 4.94–6.38). The corresponding incidence rates were 26,148 MACE cases and 16,441 deaths per 100,000 person-years. Advanced CKD stages were associated with higher hazards of MACE and all-cause mortality after adjustment for baseline demographic and socioeconomic characteristics. Residual confounding by clinical characteristics remains possible.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Ja-Ho Leigh has the highest h-index among the authors (16).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (18)
What it cites, from open citation data, with Crossref's record of each.